InsiderDirector
Phillip Frost MD ET AL Insider Trading Activity
Every SEC Form 4 transaction reported by Phillip Frost MD ET AL, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Phillip Frost MD ET AL buying or selling?
Phillip Frost MD ET AL reported 300 open-market buys ($97.2M) and 7 sells ($225.1M) across 307 Form 4 filings at 8 companies — a net selling position of $127.8M.
Source: SEC EDGAR Form 4
What stands out
- Phillip Frost MD ET AL has reported Form 4 transactions at 8 companies; the most active, Opko Health, Inc. (OPK), accounts for 285 of 307 filings (93%).
- The most recent Form 4 was accepted on Aug 6, 2026 (2 months ago).
- In the last 12 months: 14 open-market purchases ($3.5M) and no sales.
- The largest open-market purchase in the last 12 months was $771.3K of OPKO HEALTH, INC. (OPK) on Nov 20, 2025. SEC ↗
Key Statistics (as of Aug 6, 2026)
Total Form 4 filings
307
SEC EDGAR
Companies
8
Buys (300)
$97.2M
Sells (7)
$225.1M
Insider sentiment
Net sellingNet insider flow of $127.8M in net selling, filed between Jan 23, 2018 – Aug 6, 2026.
Companies Phillip Frost MD ET AL files for
Recent Phillip Frost MD ET AL transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | COCP | Director, 10% Owner | Purchase | 10.0K | $9.8K | SEC ↗ |
| Aug 5, 2026 | COCP | Director, 10% Owner | Purchase | 75.0K | $70.6K | SEC ↗ |
| Feb 25, 2026 | COCP | Director, 10% Owner | Purchase | 20.0K | $20.0K | SEC ↗ |
| Feb 9, 2026 | COCP | Director, 10% Owner | Purchase | 50.0K | $47.3K | SEC ↗ |
| Jan 2, 2026 | COCP | Director, 10% Owner | Purchase | 50.0K | $47.3K | SEC ↗ |
| Dec 31, 2025 | COCP | Director, 10% Owner | Purchase | 20.0K | $19.3K | SEC ↗ |
| Dec 29, 2025 | COCP | Director, 10% Owner | Purchase | 65.0K | $63.2K | SEC ↗ |
| Nov 28, 2025 | COCP | Director, 10% Owner | Purchase | 4.0K | $4.0K | SEC ↗ |
| Nov 26, 2025 | COCP | Director, 10% Owner | Purchase | 20.0K | $18.8K | SEC ↗ |
| Nov 21, 2025 | OPK | CEO & Chairman | Purchase | 580.0K | $768.8K | SEC ↗ |
| Nov 20, 2025 | OPK | CEO & Chairman | Purchase | 580.0K | $771.3K | SEC ↗ |
| Nov 19, 2025 | OPK | CEO & Chairman | Purchase | 580.0K | $759.1K | SEC ↗ |
| Nov 18, 2025 | OPK | CEO & Chairman | Purchase | 533.3K | $678.9K | SEC ↗ |
| Oct 31, 2025 | OPK | CEO & Chairman | Purchase | 150.0K | $213.4K | SEC ↗ |
| Aug 8, 2025 | OPK | CEO & Chairman | Purchase | 675.0K | $891.0K | SEC ↗ |
| Jun 11, 2025 | NNUP | 10% Owner | Purchase | 195.9K | $215.4K | SEC ↗ |
| Apr 10, 2025 | OPK | CEO & Chairman | Purchase | 125.0K | $169.7K | SEC ↗ |
| Apr 8, 2025 | OPK | CEO & Chairman | Purchase | 125.0K | $184.7K | SEC ↗ |
| Apr 1, 2025 | OPK | CEO & Chairman | Purchase | 100.0K | $164.8K | SEC ↗ |
| Mar 28, 2025 | OPK | CEO & Chairman | Purchase | 150.0K | $254.4K | SEC ↗ |
| Mar 17, 2025 | OPK | CEO & Chairman | Purchase | 200.0K | $347.8K | SEC ↗ |
| Mar 1, 2025 | OPK | CEO & Chairman | Purchase | 67.4K | $115.3K | SEC ↗ |
| Jan 28, 2025 | OPK | CEO & Chairman | Purchase | 47.5K | $70.1K | SEC ↗ |
| Jan 17, 2025 | OPK | CEO & Chairman | Purchase | 150.0K | $220.4K | SEC ↗ |
| Jan 15, 2025 | OPK | CEO & Chairman | Purchase | 500.0K | $740.9K | SEC ↗ |
Showing the 25 most recent filings of 307. Screen every filing.
Phillip Frost MD ET AL insider trading FAQ
Is Phillip Frost MD ET AL buying or selling?
Across 307 SEC Form 4 filings, Phillip Frost MD ET AL reported 300 open-market purchases totaling $97.2M and 7 sales totaling $225.1M — a net selling position of $127.8M.
Which companies does Phillip Frost MD ET AL file Form 4s for?
Phillip Frost MD ET AL has reported insider transactions at 8 companies, most often Opko Health, Inc. (OPK), Cocrystal Pharma, Inc. (COCP), VECTOR GROUP LTD (VGR), BioCardia, Inc. (BCDA), LADENBURG THALMANN FINANCIAL SERVICES INC. (LTS).
How far back does Phillip Frost MD ET AL's filing history go?
Trabud holds Phillip Frost MD ET AL's SEC Form 4 filings from Jan 23, 2018 – Aug 6, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Phillip Frost MD ET AL's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Phillip Frost MD ET AL and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener